Homologous News and Research

RSS
The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Vaccine effectiveness against COVID-19 severity in the elderly

Vaccine effectiveness against COVID-19 severity in the elderly

Study models SARS-CoV-2 M protein monomer and dimer 3D structures

Study models SARS-CoV-2 M protein monomer and dimer 3D structures

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Current progress in SARS-CoV-2 vaccine candidates

Current progress in SARS-CoV-2 vaccine candidates

How effective is mRNA vaccination in multiple myeloma patients?

How effective is mRNA vaccination in multiple myeloma patients?

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

A promising new vaccine for SARS-CoV-2 and influenza

A promising new vaccine for SARS-CoV-2 and influenza

Study explores the boosting of SARS-CoV-2 adenovirus vaccine-induced immunity by capsid decoration

Study explores the boosting of SARS-CoV-2 adenovirus vaccine-induced immunity by capsid decoration

Study shows SARS-CoV-2 hijacks mitochondrial transcriptional machinery resulting in organ failure and death

Study shows SARS-CoV-2 hijacks mitochondrial transcriptional machinery resulting in organ failure and death

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

New finding may aid in development of vaccines against future animal-to-human viral diseases

New finding may aid in development of vaccines against future animal-to-human viral diseases

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden